Skip to main content

Harris Todd's Form 4 filing

Tyra Biosciences, Inc. (TYRA) · filed Feb 6, 2024

Accession no.
0000950170-24-011879
Filed
Feb 6, 2024
Trade date
Feb 2-5, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $1.66M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Harris ToddCIK 0001711463Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2024Common StockSSaleDisposed−78,996$16.45F2−$1,299,484.21,523,701Direct
Feb 2, 2024Common StockSSaleDisposed−7,187$17.04F3−$122,466.481,516,514Direct
Feb 5, 2024Common StockSSaleDisposed−13,817$16.97F4−$234,474.491,502,697Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.00 to $16.9995. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.00 to $17.16. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.51 to $17.32. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)